← All trials
NCT03412071
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 7, 2017
- Primary completion
- Dec 7, 2019
- Completion date
- Dec 7, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 125
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of TorontoLead sponsor
- University of TorontoReponsible party - principal investigator
- University of TorontoOverall official - principal investigator
- University of TorontoStudy director
- Entebbe General HospitalCollaborator
- Medical Research Council-UVRI Uganda Research Unit on AIDSCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.